Daniel Spratt



Dan Spratt, MD, is an international leader in Genitourinary malignancies. In addition to his medical training at Vanderbilt University where he obtained his medical degree, he completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Spratt is an Associate Professor, the Laurie Snow Endowed Professor of Research, Vice Chair of Research in the Department of Radiation Oncology, and Chair of the Genitourinary Division of Clinical Research for the Rogel Cancer Center. Dr. Spratt has published over 200 manuscripts in journals including NEJM, JAMA, Cell, Cancer Discovery, Lancet Oncology, and JCO. He is the intact lead for the NRG Genitourinary Committee, is the National co-PI for the NRG GU006 (BALANCE trial), and is the North American PI for the next arm of the STAMPEDE trial. He has received funding from the NIH, DOD, and multiple foundations.